From the perspective of pharmaceutical systems strengthening, SIAPS worked across all functions of a health system, from governance to financing, and across the five major health and disease areas:
- HIV and AIDS
- Malaria
- Neglected tropical diseases
- Reproductive, maternal, newborn, and child health
- Tuberculosis
SIAPS aimed to improve access to and appropriate use of medical products and services for all health and disease areas, understanding that they are all closely connected. The program worked to propose innovative approaches and develop policy and technical guidelines to support the unique requirements of disease programs, including managing the introduction and expansion of new medicines and technologies.
The world’s poorest and most vulnerable people bear the greatest burden associated with these diseases. SIAPS’ efforts to improve access to high-quality medicines, vaccines, and other health technologies contributed to improving maternal and child health and combating HIV, malaria, and other diseases.
